Strota/ Newsroom/ 2026-08-12

ADVENZYMES (ADVENZYMES): Buyback

Strota Newsroom · session of 2026-08-12 · 11 Aug 18:22 · ADVENZYMES stock page →

Advanced Enzyme Technologies Limited has submitted the Exchange the Board Resolution of Buyback Historically, buyback events have moved ADVENZYMES-type stocks in the bullish direction 57.1% of the next sessions (n=42).

Advanced Enzyme Technologies has told the exchanges that its board passed a resolution on a share buyback. According to the NSE filing, timestamped 11 Aug 18:22, what was lodged is the board resolution itself. The same catalyst feed carries three acquisition intimations from the company on 8, 9 and 10 August. Nothing in the evidence gives the buyback's size, its price, or its route.

Strota keeps its own record of what followed disclosures of this type. Across 42 past buyback intimations, spread over many different stocks, the next session closed higher 57.1% of the time, and the average move was 0.374% after subtracting the market's ambient drift and a round-trip trading cost. That is a base rate for the event category, not a projection for this company: events like this have historically leaned the filer's way by a very thin margin, and one filing can land far from an average that thin.

The pack puts the market capitalisation at 3,378 crore rupees, the price-to-earnings multiple - the price paid per rupee of annual profit - at 19.79 on earnings per share of 15.24, and price-to-book at 2.07. Return on equity is 11% and the dividend yield 0.85%. The Nifty was 0.15% lower on the day.

What the evidence establishes is the filing and the base rate, little more. The six news items in the pack are at least 15 days old, all predate the resolution, and none reports on it. The sector is recorded as unknown, so no peer comparison is possible. The data does not establish why the board moved now.

The catalyst

Advanced Enzyme Technologies Limited has submitted the Exchange the Board Resolution of Buyback (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Buyback tends to continue — the move went bullish in about 57.1% of next sessions (net 0.374% after drift and cost, n=42). A base rate, not a forecast for this stock.

ADVENZYMES right now

P/E 19.79. Full ADVENZYMES analysis →

Sources

Advanced Enzyme Technologies Limited has submitted the Exchange the Board Resolution of Buyback — NSE
Advanced Enzyme Technologies Ltd Revenue Breakdown – NSE:ADVENZYMES — TradingView
Income Investors Should Know That Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Goes Ex-Dividend Soon — simplywall.st
If EPS Growth Is Important To You, Advanced Enzyme Technologies (NSE:ADVENZYMES) Presents An Opportunity — simplywall.st
Advanced Enzyme Technologies Ltd Actuals & Estimates (NSE:ADVENZYMES) — TradingView

Keep digging

ADVENZYMES — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
Newsroom: the other stocks in play this session.

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.